KRAS and cancer: ID8-KRAS floating cells showed significantly higher proportion of EdU-positive cells in GFP-positive cancer cells than ID8 floating cells (ID8 14.8 ± 3.7% vs. ID8-KRAS 26.1 ± 2.4%, p < 0.05) (Fig. 3a and b).